title: [Tau imaging].
abstract: Several promising tau imaging probes have been developed by Tohoku University ([18F]THK series), National Institute of Radiological Sciences([11C]PBB3), Eli Lilly ([18F]T807), and Hoffman-La Roche ([18F]R06958948). In this paper we discussed some of the criteria required for the tau imaging probe in Alzheimer's disease. It will be certain that tau imaging plays an important role in an accurate diagnosis and as companion diagnostics.
authors.forename: Yukitsuka
authors.initials: Y
authors.lastname: Kudo
authors.forename: Shozo
authors.initials: S
authors.lastname: Furumoto
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Harada
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Okamura
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis* / Q000378:metabolism; D003071:Cognition; D006801:Humans; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000737:chemistry; D016875:tau Proteins / Q000032:analysis* / Q000378:metabolism
chemical_list: D019275:Radiopharmaceuticals; D016875:tau Proteins